These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24713240)

  • 1. [Diagnostic pathology in the era of molecular medicine].
    Zhang B; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):1-3. PubMed ID: 24713240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology is precision medicine at the service of the patient].
    Idoate Gastearena MA
    Rev Esp Patol; 2020; 53(1):1-2. PubMed ID: 31932003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surgical pathology in the era of molecular medicine].
    Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):3-4. PubMed ID: 19489216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 6. Theranostic imaging of cancer.
    Penet MF; Chen Z; Kakkad S; Pomper MG; Bhujwalla ZM
    Eur J Radiol; 2012 Sep; 81 Suppl 1(0 1):S124-6. PubMed ID: 23083557
    [No Abstract]   [Full Text] [Related]  

  • 7. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytological material for molecular pathology].
    Heukamp LC; Bubendorf L
    Pathologe; 2015 Nov; 36(6):566-71. PubMed ID: 26483251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status and application of molecular pathoogy in development of personalized medicine in cancer therapy].
    Zeng X; Liang Z
    Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):3-5. PubMed ID: 27264321
    [No Abstract]   [Full Text] [Related]  

  • 12. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular diagnostics in pathology].
    Stenzinger A; Penzel R; Endris V; Weichert W
    Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine.
    Dumur CI; Idowu MO; Powers CN
    Cancer Cytopathol; 2013 Feb; 121(2):61-71. PubMed ID: 22887782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making molecular diagnostics ready for prime time.
    Jonietz E
    Cancer Discov; 2011 Nov; 1(6):OF1-3. PubMed ID: 22586659
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
    Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
    Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology in therapeutics: where are we now, and where are we going?
    Harrison DJ; Faratian D
    Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
    [No Abstract]   [Full Text] [Related]  

  • 18. Precision Medicine Requires Precision Laboratories.
    Rajeevan MS; Li T; Unger ER
    J Mol Diagn; 2017 Mar; 19(2):226-229. PubMed ID: 28130021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular Pathology Diagnosis as Companion Diagnostics].
    Fujii S
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):383-387. PubMed ID: 38644301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathology Informatics.
    Roy S
    Surg Pathol Clin; 2015 Jun; 8(2):187-94. PubMed ID: 26065793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.